Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02SAD
|
||||
Former ID |
DNC007082
|
||||
Drug Name |
3-(2-(4-methoxycinnamyl)phenyl)acrylic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528393] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H18O3
|
||||
Canonical SMILES |
COC1=CC=C(C=C1)C=CCC2=CC=CC=C2C=CC(=O)O
|
||||
InChI |
1S/C19H18O3/c1-22-18-12-9-15(10-13-18)5-4-8-16-6-2-3-7-17(16)11-14-19(20)21/h2-7,9-14H,8H2,1H3,(H,20,21)/b5-4+,14-11+
|
||||
InChIKey |
UIMOCAMZLBHNCQ-CTLAPNPFSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Prostaglandin E2 receptor, EP4 subtype | Target Info | Inhibitor | [528393] | |
Prostaglandin E2receptor, EP2 subtype | Target Info | Inhibitor | [528393] | ||
Prostaglandin E2 receptor EP3 subtype | Target Info | Inhibitor | [528393] | ||
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Inflammatory mediator regulation of TRP channels | |||||
Renin secretion | |||||
Pathways in cancerhsa04024:cAMP signaling pathway | |||||
Pathways in cancerhsa04020:Calcium signaling pathway | |||||
cAMP signaling pathway | |||||
Regulation of lipolysis in adipocytes | |||||
Pathways in cancer | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.